Kumada H - Search Results

1

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.

Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Among authors: kumada h. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.

2

Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy.

Akuta N, Suzuki F, Tsubota A, Arase Y, Suzuki Y, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. Akuta N, et al. Among authors: kumada h. Dig Dis Sci. 2002 Feb;47(2):405-14. doi: 10.1023/a:1013742727165. Dig Dis Sci. 2002. PMID: 11855559 Clinical Trial.

3

Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load.

Tsubota A, Akuta N, Suzuki F, Suzuki Y, Someya T, Kobayashi M, Arase Y, Saitoh S, Ikeda K, Kumada H. Tsubota A, et al. Among authors: kumada h. Intervirology. 2002;45(1):33-42. doi: 10.1159/000050085. Intervirology. 2002. PMID: 11937769

4

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.

Arase Y, Tsubota A, Saitoh S, Suzuki Y, Kobayashi M, Suzuki F, Someya T, Akuta N, Ikeda K, Kobayashi M, Kumada H. Arase Y, et al. Among authors: kumada h. Hepatol Res. 2002 Jun;23(2):98-104. doi: 10.1016/s1386-6346(01)00169-3. Hepatol Res. 2002. PMID: 12048063

5

Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis.

Ikeda K, Kobayashi M, Someya T, Saitoh S, Tsubota A, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Ikeda K, et al. Among authors: kumada h. Intervirology. 2002;45(2):71-8. doi: 10.1159/000063230. Intervirology. 2002. PMID: 12145538

6

Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinoma.

Kobayashi M, Ikeda K, Someya T, Akuta N, Suzuki F, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Kumada H. Kobayashi M, et al. Among authors: kumada h. Oncology. 2002;63(2):139-44. doi: 10.1159/000063808. Oncology. 2002. PMID: 12239448 Clinical Trial.

7

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.

Akuta N, Suzuki F, Tsubota A, Suzuki Y, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: kumada h. J Hepatol. 2002 Dec;37(6):831-6. doi: 10.1016/s0168-8278(02)00301-x. J Hepatol. 2002. PMID: 12445425

8

Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort study.

Akuta N, Tsubota A, Suzuki F, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: kumada h. J Hepatol. 2003 Jan;38(1):91-7. doi: 10.1016/s0168-8278(02)00335-5. J Hepatol. 2003. PMID: 12480565

9

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.

Suzuki F, Tsubota A, Akuta N, Someya T, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H. Suzuki F, et al. Among authors: kumada h. J Gastroenterol. 2002;37(11):922-7. doi: 10.1007/s005350200155. J Gastroenterol. 2002. PMID: 12483247 Clinical Trial.

10

Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy.

Akuta N, Suzuki F, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: kumada h. J Med Virol. 2003 Mar;69(3):376-83. doi: 10.1002/jmv.10299. J Med Virol. 2003. PMID: 12526048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters